BiFlow Medical

Company Overview

Snapshot

Founded in December 2010 by Oren Shuster and Haim Ackerman, BiFlow Medical operates with 1–10 employees. The company has secured funding across two rounds. Its last funding round occurred in July 2019.

Business overview

BiFlow Medical is a Health Tech & Life Sciences company focused on developing minimally invasive therapies for abdominal aortic aneurysm (AAA). The company's core technology involves a mechanism integrating two unique stents: a side-branch stent and an extension graft stent. This innovation aims to enable blood flow through the renal artery, expanding the patient population eligible for endovascular aneurysm repair (EVAR) and ultimately replacing traditional AAA surgeries. BiFlow Medical operates in the Medical Devices and Medical Treatment & Therapeutics sectors, serving healthcare providers.

Company Intelligence Q&A

What is BiFlow Medical's primary focus?

BiFlow Medical develops minimally invasive therapies for abdominal aortic aneurysm (AAA) using a side-branch stent and an extension graft stent to facilitate endovascular repair.

When was BiFlow Medical founded?

BiFlow Medical was founded in December 2010.

Who are the founders of BiFlow Medical?

BiFlow Medical was co-founded by Oren Shuster and Haim Ackerman.

When did BiFlow Medical last raise funding?

BiFlow Medical secured funding in July 2019 from investors including Shizim Group.

Which investors participated in BiFlow Medical's September 2014 funding round?

In September 2014, BiFlow Medical received funding from investors such as NGT3.